Year after year, Lankenau Heart Institute, its physicians, nurses and staff are recognized by their peers in the medical community, by the media and by leading health care organizations for their clinical excellence, quality and professionalism and for their commitment to patient service.
2018 Mission: Lifeline® Gold Receiving Quality Achievement Award
Lankenau Medical Center and Paoli Hospital have received the 2018 Mission: Lifeline® Gold Receiving Quality Achievement Award for implementing specific quality measures outlined by the American Heart Association for the treatment of high risk emergencies including heart attack, stroke and cardiac arrest to help save lives and improve patient outcomes.
2018 Mission: Lifeline® Silver Plus Receiving Quality Achievement Award
Bryn Mawr Hospital and Riddle Hospital have received the 2018 Mission: Lifeline SILVER Receiving achievement award for implementing specific quality measures outlined by the American Heart Association for the treatment of high risk emergencies including heart attack, stroke and cardiac arrest to help save lives and improve patient outcomes.
Among the region's best
Main Line Health hospitals have been ranked among the top hospitals in the Philadelphia region by U.S. News & World Report in aortic valve surgery, heart bypass surgery and heart failure.
50 Top Cardiovascular Hospitals
For the tenth year, Lankenau Medical Center, part of Main Line Health’s Lankenau Heart Institute, has been named one of the nation’s 50 Top Cardiovascular Hospitals® by Truven Health Analytics. Lankenau was also the only hospital in Pennsylvania to be named to the list this year. Truven’s study uses a balanced national scorecard of hospital performance metrics to identify the 50 highest-performing cardiovascular services lines in the nation. The processes used to calculate and measure hospital service lines leverages industry-leading, risk-adjusted methodologies, developed and maintained by Truven Health scientists over several years. These processes are widely regarded as the leading program for evaluating leadership impact in a hospital, as well as evaluating quality indicators and efficiencies. Lankenau continues to deliver significantly higher inpatient survival rates and shorter hospital stays for patients with heart failure or who have experienced a heart attack.
100 Hospitals and Health Systems with Great Heart Programs
Becker’s Hospital Review has named Lankenau Medical Center, part of Main Line Health’s Lankenau Heart Institute, among its list of 100 Hospitals and Health Systems with Great Heart Programs. The award recognizes hospitals leading the nation in cardiovascular care.
Nationally Recognized for Quality in Cardiac Care
Independence Blue Cross has recognized Lankenau Medical Center as a Blue Distinction® Center+ in the Blue Distinction Centers for Cardiac Care program, part of the Blue Distinction Specialty Care program. Blue Distinction Centers are nationally designated health care facilities shown to deliver improved patient safety and better health outcomes, based on objective measures that were developed with input from the medical community.
Blue Distinction Center+ for Cardiac Care designation recognizes Lankenau Medical Center for demonstrating its expertise in delivering safe and effective cardiac care, focusing on cardiac valve surgery, coronary artery bypass graft (CABG) and percutaneous coronary interventions (PCI) episodes of care. It also recognizes Bryn Mawr Hospital for demonstrating its expertise in delivering safe and effective cardiac care, focusing on percutaneous coronary interventions (PCI) episodes of care.
Blue Distinction Centers (BDC) met overall quality measures, developed with input from the medical community. A Local Blue Plan may require additional criteria for providers located in its own service area; for details, contact your Local Blue Plan. Blue Distinction Centers+ (BDC+) also met cost measures that address consumers’ need for affordable healthcare. Each provider’s cost of care is evaluated using data from its Local Blue Plan. Providers in CA, ID, NY, PA, and WA may lie in two Local Blue Plans’ areas, resulting in two evaluations for cost of care; and their own Local Blue Plans decide whether one or both cost of care evaluation(s) must meet BDC+ national criteria. National criteria for BDC and BDC+ are displayed on bcbs.com. Individual outcomes may vary. For details on a provider's in-network status or your own policy's insurance coverage, contact your local Local Blue Plan and ask your provider before making an appointment. Neither Blue Cross and Blue Shield Association nor any Blue Plans are responsible for non-covered charges or other losses or damages resulting from Blue Distinction or other provider finder information or care received from Blue Distinction or other providers.
Joint Commission “Gold Seal of Approval”
Our facility voluntarily underwent a thorough evaluation by The Joint Commission. The goal of the evaluation? To see if our facility meets The Joint Commission’s rigorous performance standards in delivering quality, safe care. By meeting these standards, our facility received The Joint Commission Gold Seal of Approval® – an internationally recognized symbol of quality.
Accreditation means that our staff has made an extra effort to review and improve the key areas that can affect the quality and safety of your care. Specially trained health care professionals who are experts in their fields visited this facility to conduct a review that monitors how well our staff: provide a safe environment for your care; educate you about the risks and options for your diagnosis and treatment; protect your rights as a patient; evaluate your condition, before, during and after diagnosis and treatment; protect you against infection; and plan for emergency situations.
In addition, Lankenau Medical Center was named a Top Performer on Key Quality Measures® by The Joint Commission for the second year. The hospitals are being recognized for exemplary performance in using evidence-based clinical processes that are shown to improve care for heart attack, heart failure, pneumonia and surgical care.
Rated by The Society of Thoracic Surgeons in the Highest Quality Tier for Cardiac Surgery
The Society is leading the way in public reporting through its collaboration with Consumers Union and its STS Public Reporting Online initiative, available to participants in the Adult Cardiac Surgery Database and Congenital Heart Surgery Database.
Get With the Guidelines®—Gold Plus Honor Roll and Elite Plus
Main Line Health hospitals have received the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Gold Plus Quality Achievement Award. The award recognizes the system’s commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.
Bryn Mawr, Paoli and Riddle hospitals additionally received the Target: StrokeSM Honor Roll award and Lankenau Medical Center received Target: StrokeSM Elite Plus award. To qualify for these recognitions, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke.
American Association of Cardiovascular and Pulmonary Rehabilitation Certification
AACVPR sponsors a Cardiac and Pulmonary Rehabilitation Program Certification process, the only peer-reviewed accreditation process designed to review individual facilities for adherence to standards and guidelines developed and published by the AACVPR and other professional societies.
Accredited Target: Stroke Honor Roll
Riddle Hospital has been recognized as a recipient of the American Heart Association/American Stroke Association’s Target: Stroke Honor Roll, for improving stroke care. Over the past quarter, at least 50 percent of the hospital’s eligible ischemic stroke patients have received tissue plasminogen activator, or tPA, within 60 minutes of arriving at the hospital (known as ‘door-to-needle’ time). A thrombolytic, or clot-busting agent, tPA is the only drug approved by the U.S. Food and Drug Administration for the urgent treatment of ischemic stroke. If given intravenously in the first three hours after the start of stroke symptoms, tPA has been shown to significantly reverse the effects of stroke and reduce permanent disability.
Critical-Care Nurses’ Beacon Award
Our Intensive Care Unit (ICU) has been awarded the American Association of Critical-Care Nurses (AACN) silver-level Beacon Award for Excellence in cardiothoracic intensive care.
System Magnet® Designation
Main Line Health has received System Magnet® designation from the American Nurses Credentialing Center (ANCC), the nation's highest award for recognizing excellence in nursing care, which has been awarded to only seven percent of hospitals and 22 health systems in the nation.